Recommendation ID

What models of cross-organisational working improve clinical and cost effectiveness in relation to the suboptimal prescribing of medicines – for example, between NHS and social care, or primary and secondary care, or between NHS and commercial organisations?

Any explanatory notes
(if applicable)

NICE was aware of pockets of good practice that involve models of care consisting of cross-organisational working relating to medicines. However, no published evidence was found to show whether or not it improves patient-reported outcomes in relation to suboptimal prescribing.
This research recommendation will help to provide evidence on whether or not cross-organisational working is a cost-effective model of care when improving patient-reported outcomes for suboptimal prescribing.

Source guidance details

Comes from guidance
Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
Date issued
March 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 23/04/2015